Guy Van Meter joins Adimab
This article was originally published in Scrip
Executive Summary
Adimab, a US biotechnology company developing an integrated yeast-based antibody discovery and maturation platform, has appointed Guy Van Meter senior director, head of business development. He joins from Pfizer, where he was involved in new business initiatives around RNAi therapeutics and regenerative medicine for Pfizer's Biotherapeutics and Bioinnovation Center in San Francisco.